Immune-Onc Therapeutics raised $33M Series B venture round.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Accelerator | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$138M
Top Valuation
-
Immune-Onc Therapeutics raised $33M in a Series B round.
The round was announced on 09/18/18.